| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.26 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |